http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1430551-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8d5e518fe045499053bd631363fb5be |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-13 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-12 |
| filingDate | 1974-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1976-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1430551-A |
| titleOfInvention | Piperazine derivatives |
| abstract | 1430551 Piperazine derivatives CENTRE D'ETUDES POUR L'INDUSTRIE PHARMACEUTIQUE 24 July 1974 [24 July 1973] 32768/74 Heading C2C Compounds of the general formula (R 1-5 =H, halogen, OH, alkyl, alkoxy, CF 3 , NO 2 , NH 2 , SO 2 NH 2 or R 1+2 = OCH 2 O; R 6 = H, alkyl; R 7 = alkyl, cycloalkyl, Ph, phenylalkyl or NR 6 R 7 = saturated heterocyclic group having 5-7 ring members, optionally containing an oxygen atom or a further nitrogen atom (which may be alkyl-substituted); n = 0-5) and their acid addition and quaternary ammonium salts are prepared by standard methods e.g. reacting the appropriate N-phenyl or phenylalkylpiperazine with epichlorohydrin and reacting the product with R 6 R 7 NH, optionally followed by salt formation. The above compounds are hypocholesterolaemiants and normalipaemiants, and may be administered in the form of pharmaceutical preparations containing them in association with a carrier. |
| priorityDate | 1973-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 16.